Oct 26, 20269 min
BUFFALO, NY - October 26, 2026 – A new #casereport was #published in Volume 17 of Oncotarget on October 16, 2026, titled “WIN-MTB-2024002 – WIN International Molecular Tumor Board: A 52-year-old female with unmeasurable...
About this Podcast:
Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.Oncotarget is now indexed by MEDLINE, PubMed and PMC/PubMed.Read about the Oncotarget Scientific Integrity Process: https://www.oncotarget.com/scientific_integrity/
Pitch Analysis
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
38%
Guest openness
Selective
80/100
Required Score
Sign up to generate a grounded pitch for Oncotarget.
Signup to Generate a PitchQuestions about Oncotarget
What is Oncotarget about?
Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed. Oncotarget is now indexed by MEDLINE, PubMed and PMC/PubMed.
What has Oncotarget covered recently?
Recent episodes include "International Tumor Board Explores Personalized Treatment Strategies for Colon Cancer Without Measurable Disease" (26 October 2026, 9 minutes), "International Tumor Board Explores Personalized Treatment Options for Glioblastoma With MDM2 and EGFR Amplifications" (22 October 2026, 9 minutes), and "Molecular Tumor Board Maps Precision Treatment Options for a Woman With Multiple Primary Cancers" (20 October 2026, 17 minutes).
How often does Oncotarget publish?
Oncotarget publishes roughly weekly, with episodes averaging 8 minutes across 500 episodes.
How hard is it to get booked on Oncotarget?
Booking probability for Oncotarget is 38%, and the host is rated Selective on guests. Oncotarget requires a Pod Score of 80 or higher. Oncotarget's contact route on record: verified email.
Who should pitch Oncotarget?
The strongest fits for Oncotarget are Scientific Research & Development. Oncotarget has a science audience and around 4,800 subscribers on YouTube.
About the host
Oncotarget is a science podcast with 500 episodes published.
Verified host email: ████████@████.comSign in to unlock →
Recent episodes
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Oct 22, 20269 minBUFFALO, NY – October 22, 2026 – A new #case report was #published in Volume 17 of Oncotarget on October 16, 2026, titled “Case Report WIN-MTB-2024001 – WIN International Molecular Tumor Board: A 55-year-old male with...
Oncotarget
Molecular Tumor Board Maps Precision Treatment Options for a Woman With Multiple Primary Cancers
Oct 20, 202617 minWhen one person develops several cancers over the course of many years, treatment decisions can become increasingly difficult. Each tumor may have a different biological origin, yet some may share genetic alterations...
Oncotarget
Pan-Cancer Analysis Identifies Buckwheat-Derived Compound as Potential AKT1 Drug-Design Candidate
Oct 14, 20268 minBUFFALO, NY – October 14, 2026 – A new #research paper was #published in Volume 17 of #Oncotarget on October 12, 2026, titled “Integrative pan-cancer analysis of AKT1 and structure-based drug design by buckwheat derived...
Oct 6, 202614 minCancer cells often survive by disrupting the molecular pathways that normally eliminate damaged or abnormal cells. One of these pathways is apoptosis, a tightly controlled form of programmed cell death. New research...
View More
Sep 28, 20266 minBUFFALO, NY – September 28, 2026 – A new #editorial was #published in Volume 17 of Oncotarget on September 23, 2026, titled “Gut feeling: Microbes at the heart of cancer therapy.” The article examines how the human...
Sep 23, 202611 minCancer cells do not grow in isolation. Their ability to survive and form tumors depends partly on how they interact with immune cells in the surrounding tumor microenvironment. Melanoma is particularly responsive to...
Sep 17, 20262 minBUFFALO, NY – September 17, 2026 – A new #commentary was #published in Volume 17 of Oncotarget on September 11, 2026, titled “Are both COVID-19 and COVID-19 vaccines associated with cancer?” The paper was authored by...
Sep 9, 20267 minBUFFALO, NY – September 9, 2026 – A new #review was #published in Volume 17 of Oncotarget on September 8, 2026, titled “Re-expression of MHC-I to treat CNS cancers.” The review examines emerging strategies to restore...
Sep 8, 202613 minHead and neck squamous cell carcinoma (HNSCC) can return even after patients complete surgery, radiation, chemotherapy, or combinations of these treatments. Preventing recurrence therefore remains an important challenge...
- Sep 8, 20263 min
BUFFALO, NY - September 8, 2026 – Oncotarget is proud to support the WIN 2026 Symposium, organized by the Worldwide Innovative Networking (WIN) Consortium, taking place October 2–3, 2026, at the Rhode Island Convention...
Oncotarget
Tumor-Derived Extracellular Vesicles Show Promise for Earlier Detection of Metastatic Risk
Sep 1, 20266 minBUFFALO, NY – September 1, 2026 – A new #review was published in Volume 17 of Oncotarget on August 28, 2026, titled “Emerging biomedical imaging applications of tumor-derived extracellular vesicles for premetastatic...
Oncotarget
Tumor-Infiltrating Lymphocyte Therapy Offers a Promising Approach for Treating Solid Tumors
Aug 31, 20264 minBUFFALO, NY – August 31, 2026 – A new #editorial was published in Volume 17 of Oncotarget on June 8, 2026, titled “Tumor infiltrating lymphocyte (TIL) therapy for treating the solid tumors: Challenges and future...
Aug 28, 20264 minBUFFALO, NY – August 28, 2026 – A new #research paper was published in Volume 17 of Oncotarget on August 19, 2026, titled “Incidence of KRAS G12C mutations in genitourinary malignancies; emerging target in precision...
Aug 25, 20267 minBUFFALO, NY – August 25, 2026 – A new precision oncology paper was #published in Volume 17 of Oncotarget on August 14, 2026, titled “Systematic methodological flaws in DNA contamination assessment of mRNA vaccines: A...
Oncotarget
Experimental Compounds Push Cancer-Promoting Pathways Into Overdrive in Pancreatic Cancer Cells
Aug 24, 202616 minPancreatic cancer remains one of the most difficult cancers to treat, in part because mutations in the KRAS gene are extraordinarily common in pancreatic ductal adenocarcinoma (PDAC). These mutations keep...
Aug 10, 20267 minBUFFALO, NY – August 10, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on August 7, 2026, titled “Delayed growth of SK-ES-1 Ewing sarcoma tumor xenografts is associated with reduced Trk and...
Aug 10, 20269 minColorectal cancer does not develop in isolation. Cancer cells exist within a complex tumor microenvironment made up of fibroblasts, immune cells, blood vessels, and extracellular matrix. Increasing evidence suggests...
Jul 28, 20269 minNutrition plays a critical role in cancer care, yet it is often overlooked. Many patients experience weight loss, muscle wasting, treatment-related side effects, and changes in appetite that can affect their ability to...
Oncotarget
Molecular Tumor Board Explores Personalized Treatment Strategies for Patient with Multiple Cancers
Jul 22, 20266 minBUFFALO, NY – July 22, 2026 – A new #PrecisionOncology paper was #Published in Volume 17 of Oncotarget on July 21, 2026, titled “WIN-MTB-2024017 – WIN International Molecular Tumor Board: A 48-year-old female with...
Recent guests
Recent guests on Oncotarget. Study who booked and why before you pitch.
J
John Michel
Brigadier General (ret.), Loyola University of Maryland
D
Dr. Lillian Siu
medical oncologist, Professor of Medicine at the University of Toronto, Scientific Lead of the Peter Gilgan Centre for Early Cancer Detection Research, Princess Margaret Cancer Centre
O
Omkar Dhaygude
Johns Hopkins University
P
Pragnesh Parmar
AIIMS Bibinagar
Best industries to pitch Oncotarget for
PitchCentric classifies Oncotarget under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Similar Podcasts
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Listen to The Lancet Oncology
33~469 listeners83% similar
Listen to The Lancet Oncology
33~469 listeners83% similar
JAMA Oncology Author Interviews
30~422 listeners79% similar
AudioScholar Oncology Weekly
20~279 listeners77% similar
Listen to The Lancet Haematology
26~366 listeners77% similar
OncTimes Talk
28~400 listeners77% similar
Podcasts like Oncotarget
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ